Korean Drug Co., Ltd. (KOSDAQ:A014570) announces a share repurchase program. Under the program, the company will repurchase up to 14,000 shares. The purpose of the program is to improve stock value through stock price stabilization and payment of incentives for retirees. The program will expire on March 14, 2021. As of December 13, 2020, the company had 104,663 shares in treasury within scope available for dividend and had 0 shares in treasury through other repurchases.